{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:44:11Z","timestamp":1791855851240,"version":"4.3.4"},"reference-count":33,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Neuroendocrine neoplasms (NENs) of the rectum (rNEN) are a rare and heterogeneous group of tumors that can vary greatly in their biological behavior, from benign to highly aggressive. While small and well-differentiated tumors can often be handled endoscopically and still face a very good prognosis, tumor size, and grade, as well as lymph node and distant metastasis, are known risk factors for impaired prognosis. This study aimed at the identification of further prognostic factors in rNEN. Methods: A retrospective analysis of patients treated for rNEN at the ENTES Center of Excellence at Charit\u00e9\u2014Universit\u00e4tsmedizin, including n = 121 patients, was performed to identify risk factors for recurrence, progression, and impaired outcome. Results: Progression-free survival (PFS) and overall survival (OS) differed significantly according to tumor grade (p &lt; 0.001). In rNET patients undergoing surgery, the Ki-67 index and distant metastases were independent risk factors for shorter PFS. Among stage I rNETs, 10 patients developed disease recurrence, associated with lymphatic invasion (1.9% vs. 30.0%, p = 0.008) and higher Ki-67 values (2 (1\u20136) vs. 2 (1\u201316), p = 0.054). Conclusions: Tumor grade and presence of metastases represent important predictive factors in rNEN. Notably, even small, early-stage rNETs can harbor a risk of recurrence when unfavorable pathological features are present, highlighting the importance of tailored, risk-adapted surveillance strategies to optimize patient outcomes.<\/jats:p>","DOI":"10.3390\/cancers17172841","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:18:15Z","timestamp":1756484295000},"page":"2841","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Factors in Neuroendocrine Neoplasms of the Rectum"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-1558","authenticated-orcid":false,"given":"Frederike","family":"Butz","sequence":"first","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Friederike","family":"M\u00fcller-Debus","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora Georgina","family":"Ecseri","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna Sophia","family":"Mani","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Akg\u00fcnd\u00fcz","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5473-5821","authenticated-orcid":false,"given":"Agata","family":"Dukaczewska","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Richard","family":"Steinhagen","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Charit\u00e9 Mitte | Campus Virchow-Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-3268","authenticated-orcid":false,"given":"Uli","family":"Fehrenbach","sequence":"additional","affiliation":[{"name":"Department of Radiology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1150-0364","authenticated-orcid":false,"given":"Catarina A.","family":"Kunze","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Jann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, DRK Kliniken Berlin K\u00f6penick, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Pratschke","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1616-9826","authenticated-orcid":false,"given":"Eva Maria","family":"Dobrindt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3676-047X","authenticated-orcid":false,"given":"Martina T.","family":"Mogl","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow Klinikum, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"O85","DOI":"10.1111\/codi.14033","article-title":"Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme","volume":"20","author":"Basuroy","year":"2018","journal-title":"Colorectal Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_4","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.dld.2019.07.011","article-title":"The ENETS TNM staging and grading system accurately predict prognosis in patients with rectal NENs","volume":"51","author":"Capurso","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1245\/s10434-019-07848-0","article-title":"Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors","volume":"27","author":"Folkert","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11605-020-04525-6","article-title":"Outcomes for a Large Cohort of Patients with Rectal Neuroendocrine Tumors: An Analysis of the National Cancer Database","volume":"25","author":"Zhao","year":"2021","journal-title":"J. Gastrointest. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rinke, A., Ambrosini, V., Dromain, C., Garcia-Carbonero, R., Haji, A., Koumarianou, A., van Dijkum, E.N., O\u2019Toole, D., Rindi, G., and Scoazec, J.Y. (2023). European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours. J. Neuroendocrinol., 35.","DOI":"10.1111\/jne.13309"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1111\/codi.15978","article-title":"Nodal metastases in small rectal neuroendocrine tumours","volume":"23","author":"Haji","year":"2021","journal-title":"Colorectal Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kim, S., Kim, E.R., Hong, S.N., Chang, D.K., Kim, Y.H., Shin, J.K., Park, Y., Huh, J.W., Kim, H.C., and Yun, S.H. (2025). Size matters: Establishing a cut-off for rectal neuroendocrine neoplasm to predict recurrence and standardize surveillance guidelines. Dig. Endosc.","DOI":"10.1111\/den.15056"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1177\/2050640619861883","article-title":"Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE)","volume":"7","author":"Fine","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Cha, J.H., Jung, D.H., Kim, J.H., Youn, Y.H., Park, H., Park, J.J., Um, Y.J., Park, S.J., Cheon, J.H., and Kim, T.I. (2019). Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-40668-6"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.dld.2025.03.023","article-title":"Risk factors for residual tumors in histologically incompletely resected rectal neuroendocrine tumors","volume":"57","author":"Park","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Park, J.S., Jeon, H.L., Park, B., Park, J.H., Lee, G.H., Lim, S.G., Shin, S.J., Lee, K.M., and Noh, C.K. (2025). Long-term outcome of grade 1 rectal neuroendocrine tumor <\/=1 cm after incomplete endoscopic resection. Clin. Endosc.","DOI":"10.5946\/ce.2025.043"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000493318","article-title":"Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)","volume":"108","author":"Sorbye","year":"2019","journal-title":"Neuroendocrinology"},{"key":"ref_16","first-page":"e139","article-title":"Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options","volume":"20","author":"Ueberroth","year":"2021","journal-title":"Clin. Colorectal Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.3748\/wjg.v30.i28.3403","article-title":"GATIS score for predicting the prognosis of rectal neuroendocrine neoplasms: A Chinese multicenter study of 12-year experience","volume":"30","author":"Zeng","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejso.2021.10.029","article-title":"Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors","volume":"48","author":"Chen","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"152642","DOI":"10.1016\/j.prp.2019.152642","article-title":"Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis","volume":"215","author":"Kang","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dabkowski, K., Skonieczna-Zydecka, K., Gawel, K., Marlicz, W., Szredzki, P., and Bialek, A. (2025). Endoscopic Submucosal Dissection and Transanal Endoscopic Microsurgery in the Treatment of Rectal Neuroendocrine Tumors: Systematic Review and Meta-Analysis of the Observational Studies. Clin. Transl. Gastroenterol.","DOI":"10.14309\/ctg.0000000000000882"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"22123","DOI":"10.18632\/oncotarget.13641","article-title":"Neuroendocrine tumors of colon and rectum: Validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systems","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/DCR.0000000000001243","article-title":"Predictors of Metastases in Rectal Neuroendocrine Tumors: Results of a National Cohort Study","volume":"61","author":"Concors","year":"2018","journal-title":"Dis. Colon Rectum"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yan, L., Xu, Y., Pan, J., Bai, J., Long, Q., He, N., Hu, P., Liu, M., Ji, H., and Li, X. (2022). Prognostic Evaluation of Patients with Rectal Neuroendocrine Neoplasms and Hepatic Metastases: A SEER Database Analysis. J. Oncol., 2022.","DOI":"10.1155\/2022\/2451282"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.gie.2018.11.010","article-title":"Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors","volume":"89","author":"Ngamruengphong","year":"2019","journal-title":"Gastrointest. Endosc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1245\/s10434-023-14829-x","article-title":"Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1\u20132 cm?","volume":"31","author":"Choi","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Li, R., Li, X., Wang, Y., Chang, C., Lv, W., Li, X., and Cao, D. (2024). Risk factors for regional lymph node metastasis in rectal neuroendocrine tumors: A population-based study. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1383047"},{"key":"ref_28","first-page":"101150","article-title":"Rectal neuroendocrine tumors: Can we predict their behavior?","volume":"31","author":"Panzuto","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100458","DOI":"10.3748\/wjg.v31.i6.100458","article-title":"GATIS score: An innovative prognostic score for rectal neuroendocrine neoplasms","volume":"31","author":"Paramythiotis","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.3748\/wjg.v30.i45.4850","article-title":"User-friendly prognostic model for rectal neuroendocrine tumours: In the era of precision management","volume":"30","author":"Chen","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1507\/endocrj.EJ22-0262","article-title":"The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: A systematic review","volume":"70","author":"Li","year":"2023","journal-title":"Endocr. J."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kim, J.Y., Kim, J., Kim, Y.I., Yang, D.H., Yoo, C., Park, I.J., Ryoo, B.Y., Ryu, J.S., and Hong, S.M. (2024). Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-54599-4"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Xu, S., Zhai, Z.Y., Zhou, P., Xue, X.F., Huang, Z.Y., Li, X.X., Yang, G.H., Bao, C.J., You, L.J., and Cui, X.B. (2024). Whole-exome sequencing reveals novel genomic signatures and potential therapeutic targets during the progression of rectal neuroendocrine neoplasm. Cell Death Dis., 15.","DOI":"10.1038\/s41419-024-07232-1"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2841\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:27Z","timestamp":1760034927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":33,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17172841"],"URL":"https:\/\/doi.org\/10.3390\/cancers17172841","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}